• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparative effects of calcium entry-blocking drugs, beta-blocking drugs, and their combination in patients with chronic stable angina.

作者信息

Kostuk W J, Pflugfelder P

出版信息

Circulation. 1987 Jun;75(6 Pt 2):V114-21.

PMID:2882870
Abstract

For monotherapy, beta-blockers and calcium-entry blockers are effective and safe antianginal medications. For prophylaxis of myocardial ischemia, a different mechanism of action for each class of drugs is reflected by the different heart rate and rate-pressure product during exercise. In patients who continue to have anginal symptoms despite adequate beta-blockade, further alleviation of symptoms together with an increase in exercise tolerance may be observed with the addition of a calcium-entry blocker. Of note is the individual patient response to the various calcium-entry blockers when combined with propranolol. Although of theoretic concern with combination therapy, no deleterious effect on left ventricular function or increased adverse clinical effects were noted in our studies. Combination therapy with beta-blockers and calcium-entry blockers is well tolerated, effective, and safe both over the short and long term in patients with exertional angina.

摘要

相似文献

1
Comparative effects of calcium entry-blocking drugs, beta-blocking drugs, and their combination in patients with chronic stable angina.
Circulation. 1987 Jun;75(6 Pt 2):V114-21.
2
Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris.钙通道阻滞剂与β受体阻滞剂联合治疗慢性稳定性心绞痛。
Am J Cardiol. 1985 Jan 25;55(3):69B-80B. doi: 10.1016/0002-9149(85)90615-0.
3
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.雷诺嗪联合阿替洛尔、氨氯地平或地尔硫䓬对严重慢性心绞痛患者运动耐量和心绞痛发作频率的影响:一项随机对照试验。
JAMA. 2004 Jan 21;291(3):309-16. doi: 10.1001/jama.291.3.309.
4
Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris.钙通道阻滞剂与β受体阻滞剂:慢性稳定型心绞痛联合治疗的利弊
Am Heart J. 1982 Sep;104(3):702-8. doi: 10.1016/0002-8703(82)90259-9.
5
Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study.普萘洛尔联合维拉帕米、硝苯地平及地尔硫䓬治疗劳力性心绞痛的临床及血流动力学评估:一项安慰剂对照、双盲、随机、交叉研究
Am J Cardiol. 1985 Mar 1;55(6):680-7. doi: 10.1016/0002-9149(85)90136-5.
6
Effort angina with adequate beta-receptor blockade: comparison with diltiazem alone and in combination.
J Am Coll Cardiol. 1986 Feb;7(2):329-35. doi: 10.1016/s0735-1097(86)80500-9.
7
Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects.钙通道阻滞剂与β-肾上腺素能阻滞剂联合用于治疗慢性稳定性心绞痛。理论依据、疗效及不良反应。
Ann Intern Med. 1988 Oct 1;109(7):570-81. doi: 10.7326/0003-4819-109-7-570.
8
Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.口服普萘洛尔与维拉帕米治疗合并系统性高血压和心绞痛的比较。一项安慰剂对照双盲随机交叉试验。
Am J Cardiol. 1982 Nov;50(5):1164-72. doi: 10.1016/0002-9149(82)90438-6.
9
Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris.四种钙拮抗剂与普萘洛尔治疗稳定型心绞痛的抗心绞痛疗效比较。
Eur J Clin Pharmacol. 1989;37(4):325-31. doi: 10.1007/BF00558494.
10
Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).钙通道阻滞剂与β受体阻滞剂联合用于运动诱发性心绞痛患者:不同类别钙通道阻滞剂的双盲平行组比较。荷兰心血管研究工作组(WCN)。
Angiology. 1999 Jun;50(6):447-54. doi: 10.1177/000331979905000602.

引用本文的文献

1
Role of calcium channel blockers in experimental exercise-induced ischemia.钙通道阻滞剂在实验性运动诱导缺血中的作用。
Cardiovasc Drugs Ther. 1988 Jan;1(5):503-12. doi: 10.1007/BF02125733.
2
Beta-adrenoceptor antagonists plus nifedipine in the treatment of chronic stable angina pectoris.
Cardiovasc Drugs Ther. 1989 Jun;3 Suppl 1:275-85. doi: 10.1007/BF00148472.
3
Profile of an ideal antianginal agent.理想抗心绞痛药物的概况。
Drugs. 1989;38 Suppl 2:1-8. doi: 10.2165/00003495-198900382-00003.
4
Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.地尔硫䓬。对其药理特性和治疗用途的重新评估。
Drugs. 1990 May;39(5):757-806. doi: 10.2165/00003495-199039050-00009.
5
Calcium-channel blockers and anaesthesia.钙通道阻滞剂与麻醉
Can J Anaesth. 1991 Jan;38(1):75-89. doi: 10.1007/BF03009168.